Preventing Neurodegeneration in Multiple Sclerosis Is Required From the Earliest Stages of the Disease

Neurology. 2022 Oct 11;99(15):641-642. doi: 10.1212/WNL.0000000000201223. Epub 2022 Aug 29.

Authors

Pablo Villoslada¹, Sara Llufriu²

Affiliations

¹ From the Institut d'investigacions Biomediques August Pi Sunyer (IDIBAPS) (P.V., S.L.), Hospital Clinic Barcelona, Spain; and Stanford University (P.V.), CA. pvillos@stanford.edu.
² From the Institut d'investigacions Biomediques August Pi Sunyer (IDIBAPS) (P.V., S.L.), Hospital Clinic Barcelona, Spain; and Stanford University (P.V.), CA.

PMID: 36038271
DOI: 10.1212/WNL.0000000000201223

No abstract available

Publication types

Editorial
Comment

MeSH terms

Brain / pathology
Disease Progression
Humans
Multiple Sclerosis* / complications
Multiple Sclerosis* / pathology
Nerve Degeneration / pathology